Chem Reports Predicts that Sofosbuvir (CAS 1190307-88-0) Market was valued USD xxxx unit in 2024 and is expected to reach USD xxxx Unit by the year 2035, growing at a CAGR of xx% globally.
Global Sofosbuvir (CAS 1190307-88-0) Market Overview:
The Global Sofosbuvir (CAS 1190307-88-0) Market Report 2024 provides a comprehensive assessment of the market’s structural factors, growth patterns, product flows, and overall size dynamics. The report evaluates both current and historical market performance to develop reliable forecasts for the period 2026–2035, offering insights into how the market is expected to evolve over the next decade.
This research is based on an extensive blend of primary data collection and secondary analytical methods. The study considers a wide range of industry-shaping elements, including regulatory frameworks, economic and market conditions, competitive developments, historical performance indicators, emerging trends, technological advancements, upcoming innovations, and the progress being made in adjacent sectors. Together, these components create a detailed and holistic understanding of the global Sofosbuvir market and its future direction.
Impact of COVID-19 on Sofosbuvir (CAS 1190307-88-0) Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Sofosbuvir (CAS 1190307-88-0) market in 2024.
Global Sofosbuvir (CAS 1190307-88-0) Market Segmentation
By Type, Sofosbuvir (CAS 1190307-88-0) market has been segmented into:
Purity ? 98%
Purity ? 98%
By Application, Sofosbuvir (CAS 1190307-88-0) market has been segmented into:
Adults Patients
Elderly Patients
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Sofosbuvir (CAS 1190307-88-0) market are:
Teva Pharmaceutical Industries Ltd
DONG BANG FUTURE TECH & LIFE CO. Ltd
Beaukev Pharma International Pvt.Ltd
DEAFARMA
Tecoland
Anhui HaiKang Pharmaceutical Co. Ltd
Shanghai Haoyuan Chemexpress Co. Ltd
Beijing Kawin Technology Share-holding Co
Hangzhou Longshine Bio-Tech Co
Global Sofosbuvir (CAS 1190307-88-0) Market – Regional Analysis
1. North America
North America remains one of the largest markets for Sofosbuvir due to the high prevalence of hepatitis C, strong healthcare infrastructure, and early adoption of innovative antiviral therapies. Demand is supported by wide insurance coverage, advanced diagnostic capabilities, and a steady shift toward combination therapies. The region also sees sustained use of generic Sofosbuvir, driven by pricing pressure and value-based reimbursement models.
Key Drivers:
2. Europe
Europe represents a mature market with consistent demand for antiviral treatments. Several countries have national programs focused on eliminating hepatitis C, which increases procurement of Sofosbuvir-based regimens. Stringent regulatory environments and cost-control policies encourage the use of affordable generics and support long-term treatment access.
Key Drivers:
3. Asia-Pacific
Asia-Pacific is one of the fastest-growing regions for Sofosbuvir due to the high patient population, rising diagnostic rates, and expanding access to treatment through public health programs. Countries like India, China, and Southeast Asian nations represent significant markets due to large-scale production, availability of low-cost formulations, and increasing government intervention to expand therapy coverage.
Key Drivers:
4. Latin America
Latin America shows steady growth, driven by government procurement programs and rising demand for low-cost antiviral therapies. Although economic challenges can limit access in some countries, increasing regional awareness and ongoing public health initiatives support moderate but consistent market expansion.
Key Drivers:
5. Middle East & Africa
The Middle East has pockets of high hepatitis C prevalence, particularly in North Africa, making it an important market for Sofosbuvir. Access remains uneven across countries—wealthier Gulf nations adopt advanced therapies quickly, while African markets rely more on generics and international health partnerships. Despite infrastructural challenges, gradual improvements in healthcare systems continue to boost demand.
Key Drivers:
Summary
The global Sofosbuvir market shows diverse regional dynamics:
1. Market Overview of Sofosbuvir (CAS 1190307-88-0)
1.1 Sofosbuvir (CAS 1190307-88-0) Market Overview
1.1.1 Sofosbuvir (CAS 1190307-88-0) Product Scope
1.1.2 Market Status and Outlook
1.2 Sofosbuvir (CAS 1190307-88-0) Market Size by Regions:
1.3 Sofosbuvir (CAS 1190307-88-0) Historic Market Size by Regions
1.4 Sofosbuvir (CAS 1190307-88-0) Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Sofosbuvir (CAS 1190307-88-0) Sales Market by Type
2.1 Global Sofosbuvir (CAS 1190307-88-0) Historic Market Size by Type
2.2 Global Sofosbuvir (CAS 1190307-88-0) Forecasted Market Size by Type
2.3 Purity ? 98%
2.4 Purity ? 98%
3. Covid-19 Impact Sofosbuvir (CAS 1190307-88-0) Sales Market by Application
3.1 Global Sofosbuvir (CAS 1190307-88-0) Historic Market Size by Application
3.2 Global Sofosbuvir (CAS 1190307-88-0) Forecasted Market Size by Application
3.3 Adults Patients
3.4 Elderly Patients
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Sofosbuvir (CAS 1190307-88-0) Production Capacity Market Share by Manufacturers
4.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Manufacturers
4.3 Global Sofosbuvir (CAS 1190307-88-0) Average Price by Manufacturers
5. Company Profiles and Key Figures in Sofosbuvir (CAS 1190307-88-0) Business
5.1 Teva Pharmaceutical Industries Ltd
5.1.1 Teva Pharmaceutical Industries Ltd Company Profile
5.1.2 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product Specification
5.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin
5.2 DONG BANG FUTURE TECH & LIFE CO. Ltd
5.2.1 DONG BANG FUTURE TECH & LIFE CO. Ltd Company Profile
5.2.2 DONG BANG FUTURE TECH & LIFE CO. Ltd Sofosbuvir (CAS 1190307-88-0) Product Specification
5.2.3 DONG BANG FUTURE TECH & LIFE CO. Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin
5.3 Beaukev Pharma International Pvt.Ltd
5.3.1 Beaukev Pharma International Pvt.Ltd Company Profile
5.3.2 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Product Specification
5.3.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin
5.4 DEAFARMA
5.4.1 DEAFARMA Company Profile
5.4.2 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product Specification
5.4.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin
5.5 Tecoland
5.5.1 Tecoland Company Profile
5.5.2 Tecoland Sofosbuvir (CAS 1190307-88-0) Product Specification
5.5.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin
5.6 Anhui HaiKang Pharmaceutical Co. Ltd
5.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Company Profile
5.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product Specification
5.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin
5.7 Shanghai Haoyuan Chemexpress Co. Ltd
5.7.1 Shanghai Haoyuan Chemexpress Co. Ltd Company Profile
5.7.2 Shanghai Haoyuan Chemexpress Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product Specification
5.7.3 Shanghai Haoyuan Chemexpress Co. Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin
5.8 Beijing Kawin Technology Share-holding Co
5.8.1 Beijing Kawin Technology Share-holding Co Company Profile
5.8.2 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product Specification
5.8.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin
5.9 Hangzhou Longshine Bio-Tech Co
5.9.1 Hangzhou Longshine Bio-Tech Co Company Profile
5.9.2 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product Specification
5.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Sofosbuvir (CAS 1190307-88-0) Market Size
6.2 North America Sofosbuvir (CAS 1190307-88-0) Key Players in North America
6.3 North America Sofosbuvir (CAS 1190307-88-0) Market Size by Type
6.4 North America Sofosbuvir (CAS 1190307-88-0) Market Size by Application
7. East Asia
7.1 East Asia Sofosbuvir (CAS 1190307-88-0) Market Size
7.2 East Asia Sofosbuvir (CAS 1190307-88-0) Key Players in North America
7.3 East Asia Sofosbuvir (CAS 1190307-88-0) Market Size by Type
7.4 East Asia Sofosbuvir (CAS 1190307-88-0) Market Size by Application
8. Europe
8.1 Europe Sofosbuvir (CAS 1190307-88-0) Market Size
8.2 Europe Sofosbuvir (CAS 1190307-88-0) Key Players in North America
8.3 Europe Sofosbuvir (CAS 1190307-88-0) Market Size by Type
8.4 Europe Sofosbuvir (CAS 1190307-88-0) Market Size by Application
9. South Asia
9.1 South Asia Sofosbuvir (CAS 1190307-88-0) Market Size
9.2 South Asia Sofosbuvir (CAS 1190307-88-0) Key Players in North America
9.3 South Asia Sofosbuvir (CAS 1190307-88-0) Market Size by Type
9.4 South Asia Sofosbuvir (CAS 1190307-88-0) Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Market Size
10.2 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Key Players in North America
10.3 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Market Size by Type
10.4 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Market Size by Application
11. Middle East
11.1 Middle East Sofosbuvir (CAS 1190307-88-0) Market Size
11.2 Middle East Sofosbuvir (CAS 1190307-88-0) Key Players in North America
11.3 Middle East Sofosbuvir (CAS 1190307-88-0) Market Size by Type
11.4 Middle East Sofosbuvir (CAS 1190307-88-0) Market Size by Application
12. Africa
12.1 Africa Sofosbuvir (CAS 1190307-88-0) Market Size
12.2 Africa Sofosbuvir (CAS 1190307-88-0) Key Players in North America
12.3 Africa Sofosbuvir (CAS 1190307-88-0) Market Size by Type
12.4 Africa Sofosbuvir (CAS 1190307-88-0) Market Size by Application
13. Oceania
13.1 Oceania Sofosbuvir (CAS 1190307-88-0) Market Size
13.2 Oceania Sofosbuvir (CAS 1190307-88-0) Key Players in North America
13.3 Oceania Sofosbuvir (CAS 1190307-88-0) Market Size by Type
13.4 Oceania Sofosbuvir (CAS 1190307-88-0) Market Size by Application
14. South America
14.1 South America Sofosbuvir (CAS 1190307-88-0) Market Size
14.2 South America Sofosbuvir (CAS 1190307-88-0) Key Players in North America
14.3 South America Sofosbuvir (CAS 1190307-88-0) Market Size by Type
14.4 South America Sofosbuvir (CAS 1190307-88-0) Market Size by Application
15. Rest of the World
15.1 Rest of the World Sofosbuvir (CAS 1190307-88-0) Market Size
15.2 Rest of the World Sofosbuvir (CAS 1190307-88-0) Key Players in North America
15.3 Rest of the World Sofosbuvir (CAS 1190307-88-0) Market Size by Type
15.4 Rest of the World Sofosbuvir (CAS 1190307-88-0) Market Size by Application
16 Sofosbuvir (CAS 1190307-88-0) Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Top Key Players Covered in Sofosbuvir (CAS 1190307-88-0) market are:
Teva Pharmaceutical Industries Ltd
DONG BANG FUTURE TECH & LIFE CO. Ltd
Beaukev Pharma International Pvt.Ltd
DEAFARMA
Tecoland
Anhui HaiKang Pharmaceutical Co. Ltd
Shanghai Haoyuan Chemexpress Co. Ltd
Beijing Kawin Technology Share-holding Co
Hangzhou Longshine Bio-Tech Co
Global Sofosbuvir (CAS 1190307-88-0) Market Segmentation
By Type, Sofosbuvir (CAS 1190307-88-0) market has been segmented into:
Purity ? 98%
Purity ? 98%
By Application, Sofosbuvir (CAS 1190307-88-0) market has been segmented into:
Adults Patients
Elderly Patients
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Upto 24 to 48 hrs (Working Hours)
Upto 72 hrs max (Working Hours) - Weekends and Public Holidays
Single User License - Allows access to only one person to the report.
Multi User License - Allows sharing with max 5 persons within organization.
Corporate License – Can be shared across entire organization.
Online Payments with PayPal
Wire Transfer / Bank Transfer
At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.
ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.
We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.
Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.
Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.